| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Scientific Officer
2 companies
Sinha Uma serves as a Director at PROK and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2019 | BBIO Bridgebio Pharma, Inc. | Chief Scientific Officer | Buy | 14,000 | $17.00 | $238,000.00 | New |